Smith & Nephew to announce Q3 trading report on 26 April 2023

SN

Smith & Nephew plc (LON:SN, NYSE: SNN), the global medical technology business, will announce its trading report for the first quarter ended Saturday, 1 April 2023 on Wednesday, 26 April 2023 at 7.00am BST / 2.00am EDT.

This will be followed by a conference call for financial analysts, at 8.30am BST / 3.30am EDT, details of which will be published on the Smith & Nephew website at https://www.smith-nephew.com/en/about-us/investors#quarterly-reporting.

Share on:

Latest Company News

Smith & Nephew cuts 2026 profit forecast despite 3.4% Q3 revenue growth

Smith & Nephew reported third-quarter revenue growth of 3.4% to $1.55bn, supported by strong demand in Sports Medicine and...

Smith & Nephew CFO John Rogers to step down in September

Smith & Nephew has announced John Rogers will leave as chief financial officer, with Pierre Palassian appointed interim CFO...

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic...

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance....

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year...

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine,...

    Search